rs11717195

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_183357.3(ADCY5):​c.1135-10970A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.185 in 152,230 control chromosomes in the GnomAD database, including 2,919 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 2919 hom., cov: 33)

Consequence

ADCY5
NM_183357.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.888

Publications

76 publications found
Variant links:
Genes affected
ADCY5 (HGNC:236): (adenylate cyclase 5) This gene encodes a member of the membrane-bound adenylyl cyclase enzymes. Adenylyl cyclases mediate G protein-coupled receptor signaling through the synthesis of the second messenger cAMP. Activity of the encoded protein is stimulated by the Gs alpha subunit of G protein-coupled receptors and is inhibited by protein kinase A, calcium and Gi alpha subunits. Single nucleotide polymorphisms in this gene may be associated with low birth weight and type 2 diabetes. Alternatively spliced transcript variants that encode different isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
ADCY5 Gene-Disease associations (from GenCC):
  • dyskinesia with orofacial involvement
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • dyskinesia with orofacial involvement, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • neurodevelopmental disorder with hyperkinetic movements and dyskinesia
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial dyskinesia and facial myokymia
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • choreatic disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_183357.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.25 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_183357.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADCY5
NM_183357.3
MANE Select
c.1135-10970A>G
intron
N/ANP_899200.1O95622-1
ADCY5
NM_001378259.1
c.1135-10970A>G
intron
N/ANP_001365188.1A0A8V8TP58
ADCY5
NM_001199642.1
c.85-10970A>G
intron
N/ANP_001186571.1O95622-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADCY5
ENST00000462833.6
TSL:1 MANE Select
c.1135-10970A>G
intron
N/AENSP00000419361.1O95622-1
ADCY5
ENST00000850916.1
c.1297-10970A>G
intron
N/AENSP00000520999.1A0ABJ7H376
ADCY5
ENST00000699718.1
c.1135-10970A>G
intron
N/AENSP00000514543.1A0A8V8TP58

Frequencies

GnomAD3 genomes
AF:
0.185
AC:
28088
AN:
152112
Hom.:
2916
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.114
Gnomad AMI
AF:
0.182
Gnomad AMR
AF:
0.256
Gnomad ASJ
AF:
0.167
Gnomad EAS
AF:
0.00250
Gnomad SAS
AF:
0.201
Gnomad FIN
AF:
0.168
Gnomad MID
AF:
0.161
Gnomad NFE
AF:
0.229
Gnomad OTH
AF:
0.160
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.185
AC:
28100
AN:
152230
Hom.:
2919
Cov.:
33
AF XY:
0.182
AC XY:
13525
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.114
AC:
4743
AN:
41534
American (AMR)
AF:
0.256
AC:
3922
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.167
AC:
579
AN:
3472
East Asian (EAS)
AF:
0.00251
AC:
13
AN:
5182
South Asian (SAS)
AF:
0.201
AC:
970
AN:
4830
European-Finnish (FIN)
AF:
0.168
AC:
1784
AN:
10596
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.229
AC:
15543
AN:
68008
Other (OTH)
AF:
0.157
AC:
332
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1183
2367
3550
4734
5917
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.205
Hom.:
5636
Bravo
AF:
0.186
Asia WGS
AF:
0.0920
AC:
320
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.52
DANN
Benign
0.71
PhyloP100
-0.89
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11717195;
hg19: chr3-123082398;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.